• Japanese
  • Korean
  • Chinese
Cover Image

Top Ten Suppliers of Synthetic Biology Technology

This report provides:

  • Identification of the top 10 companies in the market for synthetic biology technology, and the rationale behind these selections.
  • Factors taken into account, including technical innovation, market leadership, and commitment to this market via investment in products.

When selecting these top 10 companies, BCC Research looked across the industry spectrum and selected the most active and significant contributors while recognizing that there are many other contenders. Some of these “significant others” are included but to a less detailed extent than the top 10 companies.

INTRODUCTION

Recent advances allowing for the better understanding of the ways in which living DNA creates the materials of life have opened remarkable new possibilities in materials science and chemical engineering. According to physicist Freeman Dyson, “The ability to design and create new forms of life marks a turning point in the history of our species and our planet.”

These advances also mark an economic turning point, creating a market vision of synthetic life forms and life processes tailored to produce specific substances. The desired yield of such substances as biofuels can be measured in millions of tons, whereas pharmaceuticals can be measured in grams or milligrams.

The door that is opening is likely to affect important markets for decades. Intense research and development continues to be both privately and publically funded, but the work has emphatically moved out of the laboratory and into the marketplace. Major corporations are putting new intellectual properties to work in new factories in the U.S. and abroad.

The players on this new field include new companies that come directly out of university research riding large holdings of intellectual property and established multinational giants that have the networks necessary to distribute and market the new materials.

Between these two ends of the spectrum, companies are emerging that can intermediately supply the substances and services that bridge the gaps. The result is intricate patterns of interconnection between layers of the new supply chains. Acquisitions up and down these supply chains are frequent, as capital is freely available due to the obvious potential.

This document examines 10 of the top companies in the field and discusses their positions in these complex patterns of supply and demand, as well as their investments and alliances. The chosen companies have effectively positioned themselves to connect the ends of the chain from the specialized tools and materials end or acquired the ability to make the most effective use of these tools and materials.

BCC Research selected 10 companies that deserve recognition as leaders in the industry. Some are large established multinationals that have embraced the new technology. Others are startup pioneers that grow directly out of the research and development process.

They are:

  • Life Technologies
  • DNA2.0
  • Origene
  • Synthetic Genomics
  • DuPont
  • Pfizer
  • Novozymes
  • Amrys Biotechnologies
  • Scarab Genomics
  • British Petroleum

Any top 10 list has subjective elements, and thus five other companies are profiled in less detail.

STUDY GOALS AND OBJECTIVES

This document is a specialty report related to BCC Research report BIO066B by John Bergin. The goal of this document is to provide a more in-depth look at the top-tier synthetic biology companies, as well as some of the second-tier companies that are sure to play important roles in the years to come. More specifically, the objectives include identifying companies that are considered the leaders in their fields, as well as the technological means these companies are using to exploit their markets and dominate their fields.

Synthetic biology markets reviewed in this report include:

  • Markets by end-use segment, such as research and development (R&D), diagnostics/pharmaceuticals, energy, chemicals, and agriculture.
  • Markets by product type, including enabling products, biologic components, integrated systems, and enabled products.

Other major factors used to determine top companies in the field include:

  • Alliances, mergers, and acquisition strategies.
  • Financing.
  • Intellectual property (i.e., patent) portfolios.

SCOPE

This report focuses on 10 selected synthetic biology companies and the key areas in the field driving the industry growth that allows these companies to succeed. Key market segments include synthetic genes, chassis organisms, biofuels, specialty chemicals and pharmaceuticals. Another key area is industry structure, with a focus on strategic alliances and acquisitions, as well as pertinent patent information.

Table of Contents

Top Ten Suppliers of Synthetic Biology Technology

Chapter - 1: INTRODUCTION - Complimentary

  • STUDY GOALS AND OBJECTIVES
  • INTENDED AUDIENCE
  • SCOPE
  • METHODOLOGY
  • RELATED BCC REPORTS
  • BCC ONLINE SERVICES
  • DISCLAIMER

Chapter - 2: SYNTHETIC BIOLOGY OVERVIEW

  • HISTORY
  • TECHNOLOGY
    • Table 1: FORCES DRIVING THE GROWTH OF SYNTHETIC BIOLOGY
    • Table 2: LIFECYCLE STAGES IN SYNTHETIC BIOLOGY

Chapter - 3: MARKETS

  • MARKET OVERVIEW
    • Table 3: GLOBAL SYNTHETIC BIOLOGY ENABLING PRODUCT MARKET BY TYPE, THROUGH 2016
    • Table 4: GLOBAL SYNTHETIC BIOLOGY ENABLING PRODUCT MARKET BY INDUSTRY, THROUGH 2016
  • SYNTHETIC BIOLOGY MARKETS BY END USER INDUSTRY
    • Table 5: SYNTHETIC BIOLOGY PRODUCT BREAKDOWN BY END-USER INDUSTRY, 2010-2016
  • MARKET PLAYERS
    • Table 6: ESTIMATED SYNTHETIC GENE COMPANY MARKET SHARES, 2010
  • MARKET SEGMENTS
    • Table 7: GLOBAL RESEARCH AND DEVELOPMENT MARKET BY PRODUCT TYPE, THROUGH 2016
    • Table 8: GLOBAL BIOLOGIC COMPONENT MARKET BY INDUSTRY, THROUGH 2016
    • Table 9: GLOBAL SYNTHETIC BIOLOGY ENABLED BIOFUELS MARKET BY FUEL TYPE, THROUGH 2016
  • ACQUISITIONS
    • Table 10: INDUSTRY ACQUISITIONS AND THEIR STRATEGIC OBJECTIVES, 2010-2012

Chapter - 4: PATENTS

  • Table 11: INDUSTRY PATENTS BY COMPANY
  • Figure 1: PATENTS BY INDUSTRY, COMPANY AND SUBCLASS

Chapter - 5: SYNTHETIC BIOLOGY COMPANY PROFILES

  • AMYRIS BIOTECHNOLOGIES INC.
  • OTHER FARNESENE-DERIVED PRODUCTS
  • KEY MANAGEMENT
    • Table 12: AMYRIS BIODIESEL ADVANTAGES
  • BRITISH PETROLEUM
    • MANAGEMENT
      • British Petroleum
      • British Petroleum Biofuels
  • DNA2.0 INC.
    • KEY DNA2.0 PATENTS
    • PARTNERS
    • MANAGEMENT
  • E.I. DU PONT DE NEMOURS AND COMPANY
    • MANAGEMENT
      • DuPont
      • DuPont Industrial Biosciences
        • Figure 2: MAKING CELLULOSIC ETHANOL
  • LIFE TECHNOLOGIES INC.
    • LIFE TECHNOLOGIES BRANDS
      • MANAGEMENT
        • Figure 3: LIFE TECHNOLOGIES FINANCIAL SNAPSHOT
  • NOVOZYMES A/S
    • MANAGEMENT
  • ORIGENE TECHNOLOGIES
    • MANAGEMENT
  • PFIZER
    • LEADERSHIP
  • SCARAB GENOMICS LLC
    • MANAGEMENT
      • Figure 4: GENES REMOVED FROM CLEAN GENOMIC STRAINS OF E. COLI
  • SYNTHETIC GENOMICS INC.
    • MANAGEMENT
      • Table 13: SYNTHETIC GENOMICS STRATEGIC ALLIANCES

Chapter - 6: SYNTHETIC BIOLOGY COMPANY PROFILES

  • EVOLVA SA
    • EVOLVA'S GENETIC CHEMISTRY PLATFORM STEP DISCRIPTION
      • Table 14: EVOLVA STRATEGIC ALLIANCES
      • Table 15: EVOLVA PRODUCT PIPELINE
    • MANAGEMENT
  • GINKGO BIOWORKS
    • MANAGEMENT
  • ROCHE LIFE SCIENCES
    • MANAGEMENT
  • SOLAZYME INC.
    • MANAGEMENT
      • Table 16: SOLAZYME STRATEGIC ALLIANCES
  • SYNPROMICS LTD.
    • MANAGEMENT
      • Table 17: SYNTHETIC BIOLOGY TOP 10 COMPANIES
      • Table 18: UPCOMING SYNTHETIC BIOLOGY COMPANY PROFILES

List of Tables

  • Table 1: FORCES DRIVING THE GROWTH OF SYNTHETIC BIOLOGY
  • Table 2: LIFECYCLE STAGES IN SYNTHETIC BIOLOGY
  • Table 3: GLOBAL SYNTHETIC BIOLOGY ENABLING PRODUCT MARKET BY TYPE, THROUGH 2016
  • Table 4: GLOBAL SYNTHETIC BIOLOGY ENABLING PRODUCT MARKET BY INDUSTRY, THROUGH 2016
  • Table 5: SYNTHETIC BIOLOGY PRODUCT BREAKDOWN BY END-USER INDUSTRY, 2010-2016
  • Table 6: ESTIMATED SYNTHETIC GENE COMPANY MARKET SHARES, 2010
  • Table 7: GLOBAL RESEARCH AND DEVELOPMENT MARKET BY PRODUCT TYPE, THROUGH 2016
  • Table 8: GLOBAL BIOLOGIC COMPONENT MARKET BY INDUSTRY, THROUGH 2016
  • Table 9: GLOBAL SYNTHETIC BIOLOGY ENABLED BIOFUELS MARKET BY FUEL TYPE, THROUGH 2016
  • Table 10: INDUSTRY ACQUISITIONS AND THEIR STRATEGIC OBJECTIVES, 2010-2012
  • Table 11: INDUSTRY PATENTS BY COMPANY
  • Table 12: AMYRIS BIODIESEL ADVANTAGES
  • Table 13: SYNTHETIC GENOMICS STRATEGIC ALLIANCES
  • Table 14: EVOLVA STRATEGIC ALLIANCES
  • Table 15: EVOLVA PRODUCT PIPELINE
  • Table 16: SOLAZYME STRATEGIC ALLIANCES
  • Table 17: SYNTHETIC BIOLOGY TOP 10 COMPANIES
  • Table 18: UPCOMING SYNTHETIC BIOLOGY COMPANY PROFILES

List of Figures

  • Figure 1: PATENTS BY INDUSTRY, COMPANY AND SUBCLASS
  • Figure 2: MAKING CELLULOSIC ETHANOL
  • Figure 3: LIFE TECHNOLOGIES FINANCIAL SNAPSHOT
  • Figure 4: GENES REMOVED FROM CLEAN GENOMIC STRAINS OF E. COLI
Show More
Pricing